Patients with Atrial Fibrillation Undergoing Cardiac Surgery: No Left Atrial Appendage Shall Remain Untouched

Area of Science:

• Cardiology
• Medical Devices
• Surgical Procedures

Background:

• Atrial fibrillation is a common arrhythmia associated with increased risk of stroke.
• The CHA2DS2-VASc score is used to assess stroke risk in patients with atrial fibrillation.
• Left atrial appendage occlusion is a potential strategy to mitigate stroke risk.

Purpose of the Study:

• To evaluate the efficacy and safety of surgical left atrial appendage occlusion in patients undergoing cardiac surgery.
• To determine the impact of left atrial appendage occlusion on the incidence of stroke or systemic embolism.

Main Methods:

• The Left Atrial Appendage Occlusion Study III randomized 4,811 patients with atrial fibrillation and a CHA2DS2-VASc score ≥2.
• Patients were assigned to either surgical left atrial appendage occlusion or no occlusion.
• Follow-up was conducted for a mean duration of 3.8 years.

Main Results:

• Stroke or systemic embolism was reduced by 33% in the occlusion group compared to the no occlusion group.
• No early or late adverse effects were observed in the left atrial appendage occlusion group.
• The findings suggest a significant benefit of left atrial appendage occlusion in this patient population.

Conclusions:

• Surgical left atrial appendage occlusion is an effective method for reducing stroke and systemic embolism in patients with atrial fibrillation undergoing cardiac surgery.
• The procedure is safe, with no increased risk of adverse events.
• These findings have significant implications for stroke prevention strategies in patients with atrial fibrillation.